These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

754 related items for PubMed ID: 15788440

  • 1. CTLA4-CD80/CD86 interactions on primary mouse CD4+ T cells integrate signal-strength information to modulate activation with Concanavalin A.
    Mukherjee S, Ahmed A, Nandi D.
    J Leukoc Biol; 2005 Jul; 78(1):144-57. PubMed ID: 15788440
    [Abstract] [Full Text] [Related]

  • 2. Modulation of cell cycle progression by CTLA4-CD80/CD86 interactions on CD4+ T cells depends on strength of the CD3 signal: critical role for IL-2.
    Mukherjee S, Ahmed A, Malu S, Nandi D.
    J Leukoc Biol; 2006 Jul; 80(1):66-74. PubMed ID: 16624934
    [Abstract] [Full Text] [Related]

  • 3. Role of CD80, CD86, and CTLA4 on mouse CD4(+) T lymphocytes in enhancing cell-cycle progression and survival after activation with PMA and ionomycin.
    Mukherjee S, Maiti PK, Nandi D.
    J Leukoc Biol; 2002 Nov; 72(5):921-31. PubMed ID: 12429713
    [Abstract] [Full Text] [Related]

  • 4. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL.
    Lanier LL, O'Fallon S, Somoza C, Phillips JH, Linsley PS, Okumura K, Ito D, Azuma M.
    J Immunol; 1995 Jan 01; 154(1):97-105. PubMed ID: 7527824
    [Abstract] [Full Text] [Related]

  • 5. Co-stimulatory pathways controlling activation and peripheral tolerance of human CD4+CD28- T cells.
    Park W, Weyand CM, Schmidt D, Goronzy JJ.
    Eur J Immunol; 1997 May 01; 27(5):1082-90. PubMed ID: 9174596
    [Abstract] [Full Text] [Related]

  • 6. Granulocyte chemotactic protein-2 mediates adaptive immunity in part through IL-8Rbeta interactions.
    Singh UP, Singh S, Boyaka PN, McGhee JR, Lillard JW.
    J Leukoc Biol; 2004 Dec 01; 76(6):1240-7. PubMed ID: 15356099
    [Abstract] [Full Text] [Related]

  • 7. Increased expression of CD80, CD86 and CD70 on T cells from HIV-infected individuals upon activation in vitro: regulation by CD4+ T cells.
    Wolthers KC, Otto SA, Lens SM, Kolbach DN, van Lier RA, Miedema F, Meyaard L.
    Eur J Immunol; 1996 Aug 01; 26(8):1700-6. PubMed ID: 8765009
    [Abstract] [Full Text] [Related]

  • 8. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
    Habib-Agahi M, Phan TT, Searle PF.
    Int Immunol; 2007 Dec 01; 19(12):1383-94. PubMed ID: 17977894
    [Abstract] [Full Text] [Related]

  • 9. Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7-1 (CD80) and B7-2 (CD86) expression.
    Mitra RS, Judge TA, Nestle FO, Turka LA, Nickoloff BJ.
    J Immunol; 1995 Mar 15; 154(6):2668-77. PubMed ID: 7533180
    [Abstract] [Full Text] [Related]

  • 10. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K, Neena K, Chitralekha KT, Arif AK, Tomar D, Rao DN.
    Int Immunopharmacol; 2004 Jan 15; 4(1):1-14. PubMed ID: 14975355
    [Abstract] [Full Text] [Related]

  • 11. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation.
    Tao X, Constant S, Jorritsma P, Bottomly K.
    J Immunol; 1997 Dec 15; 159(12):5956-63. PubMed ID: 9550393
    [Abstract] [Full Text] [Related]

  • 12. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y, Hiraoka S, Tomura M, Zhou XY, Yashiro-Ohtani Y, Mori Y, Shimizu J, Ono S, Dunussi-Joannopoulos K, Wolf S, Fujiwara H.
    Int Immunol; 2005 Jan 15; 17(1):73-83. PubMed ID: 15569772
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The role of B7 ligands (CD80 and CD86) in CD152-mediated allograft tolerance: a crosscheck hypothesis.
    Tsai MK, Ho HN, Chien HF, Ou-Yang P, Lee CJ, Lee PH.
    Transplantation; 2004 Jan 15; 77(1):48-54. PubMed ID: 14724434
    [Abstract] [Full Text] [Related]

  • 15. Evidence for a critical role for IL-2 in CD40-mediated activation of naive B cells by primary CD4 T cells.
    Johnson-Léger C, Christenson JR, Holman M, Klaus GG.
    J Immunol; 1998 Nov 01; 161(9):4618-26. PubMed ID: 9794390
    [Abstract] [Full Text] [Related]

  • 16. Differential effects of CD28 engagement and IL-12 on T cell activation by altered peptide ligands.
    Ding L, Shevach EM.
    J Immunol; 1998 Dec 15; 161(12):6614-21. PubMed ID: 9862689
    [Abstract] [Full Text] [Related]

  • 17. Expression of costimulatory molecules CD80 and/or CD86 by a Kaposi's sarcoma tumor cell line induces differential T-cell activation and proliferation.
    Foreman KE, Wrone-Smith T, Krueger AE, Nickoloff BJ.
    Clin Immunol; 1999 Jun 15; 91(3):345-53. PubMed ID: 10370381
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Essential role of dendritic cell CD80/CD86 costimulation in the induction, but not reactivation, of TH2 effector responses in a mouse model of asthma.
    van Rijt LS, Vos N, Willart M, Kleinjan A, Coyle AJ, Hoogsteden HC, Lambrecht BN.
    J Allergy Clin Immunol; 2004 Jul 15; 114(1):166-73. PubMed ID: 15241361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.